Back to results

CompletedPhase 2

Deferiprone to Delay Dementia (The 3D Study)

NCT03234686

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

KaRa Institute of Neurological Diseases

Macquarie Park, New South Wales, Australia

+7 additional locations

View on ClinicalTrials.gov

Deferiprone to Delay Dementia (The 3D Study) — TrialFind